Has the Pandemic Changed CLL Treatment Approaches?

Has the Pandemic Changed CLL Treatment Approaches?

How has the coronavirus pandemic impacted treatment for chronic lymphocytic leukemia (CLL), both in the short term and in the long term?

In this segment from a recent CLL Answers Now program, host Andrew Schorr talks to another long-term CLL survivor Nick Bohas about his MRD results from a clinical trial and how he is staying vigilant during the coronavirus pandemic.

They are joined by Dr. Nitin Jain from the University of Texas MD Anderson Cancer Center and Dr. Alexey Danilov from City of Hope, who discuss what MRD means, if certain treatments are being used over other options because of the pandemic, and the importance of FISH and cytogenetic testing.

Although this is a sponsored program, Patient Power maintains editorial control and is solely responsible for the content of this program.

This article was originally published June 24, 2020 and most recently updated September 8, 2020.
© 2024 HealthCentral LLC. All rights reserved.

More on Chronic Lymphocytic Leukemia